JNJ-42226314
JNJ-42226314 is a potent, selective, and non-covalent inhibitor of monoacylglycerol lipase (MAGL) . Its efficacy in neuropathic and inflammatory pain models is mediated by elevating endogenous 2-arachidonoylglycerol (2-AG) levels, supporting its use in cannabinoid-related in vivo pain research.
Product Specifications
CAS Number
1252765-13-1
Product Name Alternative
JNJ 42226314, JNJ42226314, JNJ-42226314, MAGL
Field of Research
Metabolism Research
Purity
99.62% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (10.21 mM) ; DMSO:100 mg/mL (204.27 mM)
Smiles
Fc1ccc (cc1) -n1ccc2cc (ccc12) C (=O) N1CC (C1) N1CCN (CC1) C (=O) c1nccs1
Molecular Formula
C26H24FN5O2S
Molecular Weight
489.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15108752 1 Vial
Lentiviral human MEGF9 shRNA (UAS) - Lentiviral human MEGF9 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 